Moreover, SHIP-1 was significantly down-regulated in patients with late-stage MDS, and SHIP-1 expression reduced the number of colonies formed by primary patient myeloid leukemia blasts (Lee et al., 2012). This evidence concerns the gene INPP5D and myelodysplastic syndrome.